Cargando…

An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is increasing in incidence and is a leading cause of cancer-related mortality worldwide. Adherence to HCC surveillance guidelines and appropriate treatment triage of liver lesions may improve receipt of curative-intent treatment and improved survival. Late-stage HCC di...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Robert J., Jayasekera, Channa, Jones, Patricia, Kanwal, Fasiha, Singal, Amit G., Ahmed, Aijaz, Taglienti, Robert, Younossi, Zobair, Kulik, Laura, Mehta, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822660/
https://www.ncbi.nlm.nih.gov/pubmed/36660470
http://dx.doi.org/10.14740/gr1573
_version_ 1784865997688143872
author Wong, Robert J.
Jayasekera, Channa
Jones, Patricia
Kanwal, Fasiha
Singal, Amit G.
Ahmed, Aijaz
Taglienti, Robert
Younossi, Zobair
Kulik, Laura
Mehta, Neil
author_facet Wong, Robert J.
Jayasekera, Channa
Jones, Patricia
Kanwal, Fasiha
Singal, Amit G.
Ahmed, Aijaz
Taglienti, Robert
Younossi, Zobair
Kulik, Laura
Mehta, Neil
author_sort Wong, Robert J.
collection PubMed
description Hepatocellular carcinoma (HCC) is increasing in incidence and is a leading cause of cancer-related mortality worldwide. Adherence to HCC surveillance guidelines and appropriate treatment triage of liver lesions may improve receipt of curative-intent treatment and improved survival. Late-stage HCC diagnosis reflects sub-optimal implementation of effective HCC surveillance, whereas inappropriate treatment triage or linkage to care accounts for the non-receipt of curative-intent in close to half of early-stage HCC in the USA. A free, open-access decision-support tool for liver lesions that incorporates current guideline recommendations in a user-friendly interface could improve appropriate and timely triage of patients to appropriate care. This review provides a summary of gaps and disparities in linkage to HCC care and introduces a free, internet-based, interactive decision-support tool for managing liver lesions. This tool has been developed by the HCC Steering Committee of the Chronic Liver Disease Foundation and is targeted toward clinicians across specialties who may encounter liver lesions during routine care or as part of dedicated HCC surveillance.
format Online
Article
Text
id pubmed-9822660
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-98226602023-01-18 An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma Wong, Robert J. Jayasekera, Channa Jones, Patricia Kanwal, Fasiha Singal, Amit G. Ahmed, Aijaz Taglienti, Robert Younossi, Zobair Kulik, Laura Mehta, Neil Gastroenterology Res Review Hepatocellular carcinoma (HCC) is increasing in incidence and is a leading cause of cancer-related mortality worldwide. Adherence to HCC surveillance guidelines and appropriate treatment triage of liver lesions may improve receipt of curative-intent treatment and improved survival. Late-stage HCC diagnosis reflects sub-optimal implementation of effective HCC surveillance, whereas inappropriate treatment triage or linkage to care accounts for the non-receipt of curative-intent in close to half of early-stage HCC in the USA. A free, open-access decision-support tool for liver lesions that incorporates current guideline recommendations in a user-friendly interface could improve appropriate and timely triage of patients to appropriate care. This review provides a summary of gaps and disparities in linkage to HCC care and introduces a free, internet-based, interactive decision-support tool for managing liver lesions. This tool has been developed by the HCC Steering Committee of the Chronic Liver Disease Foundation and is targeted toward clinicians across specialties who may encounter liver lesions during routine care or as part of dedicated HCC surveillance. Elmer Press 2022-12 2022-12-01 /pmc/articles/PMC9822660/ /pubmed/36660470 http://dx.doi.org/10.14740/gr1573 Text en Copyright 2022, Wong et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Wong, Robert J.
Jayasekera, Channa
Jones, Patricia
Kanwal, Fasiha
Singal, Amit G.
Ahmed, Aijaz
Taglienti, Robert
Younossi, Zobair
Kulik, Laura
Mehta, Neil
An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma
title An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma
title_full An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma
title_fullStr An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma
title_full_unstemmed An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma
title_short An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma
title_sort open-access, interactive decision-support tool to facilitate guideline-driven care for hepatocellular carcinoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822660/
https://www.ncbi.nlm.nih.gov/pubmed/36660470
http://dx.doi.org/10.14740/gr1573
work_keys_str_mv AT wongrobertj anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT jayasekerachanna anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT jonespatricia anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT kanwalfasiha anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT singalamitg anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT ahmedaijaz anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT taglientirobert anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT younossizobair anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT kuliklaura anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT mehtaneil anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT wongrobertj openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT jayasekerachanna openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT jonespatricia openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT kanwalfasiha openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT singalamitg openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT ahmedaijaz openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT taglientirobert openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT younossizobair openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT kuliklaura openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma
AT mehtaneil openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma